ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/28 | 2,130 | 2,141 | 2,111 | 2,114 | -17 | -0.8% | 48,200 |
| 2024/02/27 | 2,145 | 2,147 | 2,125 | 2,131 | -18 | -0.8% | 41,300 |
| 2024/02/26 | 2,145 | 2,166 | 2,140 | 2,149 | ±0 | ±0% | 61,700 |
| 2024/02/22 | 2,176 | 2,176 | 2,138 | 2,149 | -6 | -0.3% | 69,100 |
| 2024/02/21 | 2,178 | 2,180 | 2,152 | 2,155 | -23 | -1.1% | 45,000 |
| 2024/02/20 | 2,178 | 2,192 | 2,172 | 2,178 | +5 | +0.2% | 41,700 |
| 2024/02/19 | 2,175 | 2,176 | 2,159 | 2,173 | +8 | +0.4% | 37,100 |
| 2024/02/16 | 2,162 | 2,174 | 2,139 | 2,165 | +35 | +1.6% | 62,800 |
| 2024/02/15 | 2,143 | 2,150 | 2,108 | 2,130 | -13 | -0.6% | 66,200 |
| 2024/02/14 | 2,182 | 2,182 | 2,128 | 2,143 | -39 | -1.8% | 71,500 |
| 2024/02/13 | 2,171 | 2,188 | 2,156 | 2,182 | +17 | +0.8% | 79,600 |
| 2024/02/09 | 2,180 | 2,191 | 2,150 | 2,165 | -31 | -1.4% | 85,200 |
| 2024/02/08 | 2,211 | 2,211 | 2,172 | 2,196 | -15 | -0.7% | 83,900 |
| 2024/02/07 | 2,185 | 2,211 | 2,177 | 2,211 | +25 | +1.1% | 100,500 |
| 2024/02/06 | 2,258 | 2,264 | 2,185 | 2,186 | -77 | -3.4% | 163,600 |
| 2024/02/05 | 2,146 | 2,263 | 2,126 | 2,263 | +67 | +3.1% | 287,700 |
| 2024/02/02 | 2,261 | 2,270 | 2,186 | 2,196 | +154 | +7.5% | 588,000 |
| 2024/02/01 | 2,040 | 2,048 | 2,018 | 2,042 | -9 | -0.4% | 97,900 |
| 2024/01/31 | 2,026 | 2,051 | 2,024 | 2,051 | +18 | +0.9% | 47,000 |
| 2024/01/30 | 2,050 | 2,056 | 2,033 | 2,033 | -12 | -0.6% | 52,700 |
| 2024/01/29 | 2,031 | 2,046 | 2,031 | 2,045 | +17 | +0.8% | 40,300 |
| 2024/01/26 | 2,030 | 2,041 | 2,020 | 2,028 | -5 | -0.2% | 57,600 |
| 2024/01/25 | 2,020 | 2,034 | 2,019 | 2,033 | +15 | +0.7% | 51,000 |
| 2024/01/24 | 2,029 | 2,031 | 2,004 | 2,018 | -11 | -0.5% | 57,500 |
| 2024/01/23 | 2,026 | 2,048 | 2,025 | 2,029 | -1 | ±0% | 64,000 |
| 2024/01/22 | 2,023 | 2,035 | 2,023 | 2,030 | +9 | +0.4% | 39,100 |
| 2024/01/19 | 2,032 | 2,037 | 2,014 | 2,021 | -24 | -1.2% | 79,000 |
| 2024/01/18 | 2,040 | 2,048 | 2,030 | 2,045 | -2 | -0.1% | 51,500 |
| 2024/01/17 | 2,074 | 2,079 | 2,047 | 2,047 | -15 | -0.7% | 56,900 |
| 2024/01/16 | 2,080 | 2,083 | 2,061 | 2,062 | -16 | -0.8% | 43,400 |
| 2024/01/15 | 2,063 | 2,078 | 2,052 | 2,078 | +19 | +0.9% | 50,600 |
| 2024/01/12 | 2,070 | 2,074 | 2,050 | 2,059 | +5 | +0.2% | 65,200 |
| 2024/01/11 | 2,070 | 2,072 | 2,050 | 2,054 | -9 | -0.4% | 72,500 |
| 2024/01/10 | 2,050 | 2,073 | 2,040 | 2,063 | +16 | +0.8% | 67,300 |
| 2024/01/09 | 2,053 | 2,058 | 2,034 | 2,047 | +14 | +0.7% | 50,400 |
| 2024/01/05 | 2,065 | 2,068 | 2,029 | 2,033 | -12 | -0.6% | 52,200 |
| 2024/01/04 | 2,017 | 2,054 | 1,995 | 2,045 | +28 | +1.4% | 75,400 |
| 2023/12/29 | 2,020 | 2,027 | 2,005 | 2,017 | -1 | ±0% | 41,800 |
| 2023/12/28 | 2,009 | 2,018 | 1,999 | 2,018 | +8 | +0.4% | 52,000 |
| 2023/12/27 | 2,000 | 2,012 | 1,998 | 2,010 | +8 | +0.4% | 95,900 |
| 2023/12/26 | 2,000 | 2,012 | 1,997 | 2,002 | +7 | +0.4% | 71,000 |
| 2023/12/25 | 2,000 | 2,007 | 1,993 | 1,995 | +14 | +0.7% | 88,400 |
| 2023/12/22 | 1,970 | 1,983 | 1,970 | 1,981 | +19 | +1% | 53,200 |
| 2023/12/21 | 1,960 | 1,970 | 1,959 | 1,962 | -13 | -0.7% | 34,200 |
| 2023/12/20 | 1,960 | 1,979 | 1,959 | 1,975 | +22 | +1.1% | 54,000 |
| 2023/12/19 | 1,944 | 1,953 | 1,931 | 1,953 | +9 | +0.5% | 67,600 |
| 2023/12/18 | 1,938 | 1,948 | 1,922 | 1,944 | -4 | -0.2% | 45,000 |
| 2023/12/15 | 1,975 | 1,975 | 1,946 | 1,948 | -28 | -1.4% | 105,200 |
| 2023/12/14 | 1,981 | 1,993 | 1,968 | 1,976 | -8 | -0.4% | 37,800 |
| 2023/12/13 | 1,996 | 1,996 | 1,977 | 1,984 | -14 | -0.7% | 57,900 |
51～
100
件表示中 / 3454件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 204,500円 | +9.6% | +17.5% | 2.25% | 11.56倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,000円 | +7.3% | +16.8% | 3.05% | 23.51倍 | 0.92倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| 杏林製薬 | 172,000円 | +3.2% | +4.5% | 3.02% | 19.76倍 | 0.76倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 217,000円 | +7.6% | +57.5% | 2.44% | 16.76倍 | 1.65倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割弱。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 64,000円 | -3.7% | -36.7% | 3.13% | 21.59倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
